Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Jane A. Cauley, Larry Norton, Marc E. Lippman, +16

Breast Cancer Research and Treatment

Breast OncologyOncologyMore TrialCancer ManagementClinical Trials +10

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

Barbara Obermayer‐Pietsch, Fernando Marín, Eugène McCloskey, +8

Journal of Bone and Mineral Research

Daily Teriparatide TreatmentSpine CarePrior Antiresorptive TreatmentLumbar Spine BmdBone Health +13

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

Steven Boonen, Jonathan D. Adachi, Z. Man, +10

The Journal of Clinical Endocrinology & Metabolism

Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)

Richard Eastell, Thomas Nickélsen, Fernando Marín, +11

Journal of Bone and Mineral Research

OsteopathySevere OsteoporosisGynecologySurgeryPharmacotherapy +15

Monitoring Teriparatide-Associated Changes in Vertebral Microstructure by High-Resolution CT In Vivo: Results From the EUROFORS Study

Christian Graeff, Wolfram Timm, Thomas Nickélsen, +4

Journal of Bone and Mineral Research

Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome

María José Barahona, Nuria Sucunza, Eugenia Resmini, +6

The Journal of Clinical Endocrinology & Metabolism

Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone

Christian Roux, C. Gennari, Jordi Farrerons, +7

Arthritis & Rheumatism

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis

Robert R. Recker, Fernando Marín, Sophia Ish‐Shalom, +9

Journal of Bone and Mineral Research

Biochemical MarkersGynecologySurgerySrr TreatmentOsteoporosis +14

Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib

Thomas M. R�nger, Silvano Adami, Claude-Laurent Benhamou, +7

Journal of the American Academy of Dermatology

MedicineTopical DrugClinical DermatologySkin PharmacologyWound Healing +6

Risk factors for prediction of inadequate response to antiresorptives

Adolfo Díez‐Pérez, José M. Olmos, Xavier Nogués, +12

Journal of Bone and Mineral Research